Results 131 to 140 of about 4,651,346 (275)
Translating whole‐genome doubling into precision medicine in cancer
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley +1 more source
Research on structural damage identification based on temporal power flow graph network. [PDF]
Wu X +5 more
europepmc +1 more source
Structural Damage Identification Using the Optimal Achievable Displacement Variation. [PDF]
Peng X, Tian C, Yang Q.
europepmc +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Damage identification of reinforced concrete structure based on CNN-ICSA-GWELM model. [PDF]
You W.
europepmc +1 more source
Extended Kalman filter algorithm for non-roughness and moving damage identification. [PDF]
Ding HL, Zhang C, Gao YW, Huang JP.
europepmc +1 more source
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
Dynamic Response-Based Safety Monitoring and Damage Identification of Concrete Arch Dams via PSO-LSTM. [PDF]
Qiu J +9 more
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Stiffness Separation Method for Damage Identification in Continuous Rigid Frame Bridges. [PDF]
Xiao F, Xu L, Yan Y, Xiang Y.
europepmc +1 more source

